Edwards Lifesciences Mike Mussallem To Retire As CEO, Bernard Zovighian Named Successor
Executive Summary
Mussallem’s retirement at age 70 does not come as a surprise to the Street, but analysts expect some headwinds for his successor Bernard Zovighian, who has been heading the firm’s transcatheter mitral and tricuspid valve repair business.